Search
Search Results
##search.searchResults.foundPlural##
-
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3294PDF: 1150HTML: 1921 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1033PDF: 559HTML: 743 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2343PDF: 874HTML: 970Patient’s family tree: 202 -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA
2459PDF: 890HTML: 2225New table Chinese children with APL: 182 -
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2203PDF: 812HTML: 1078Spirometry in SCA patients before transplant: 233Spirometry in SCA patients post transplant: 205 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1896PDF: 769HTML: 475 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1507PDF: 526HTML: 196 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
1191PDF: 1033Suppl. Files: 481HTML: 359 -
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
1023PDF: 752HTML: 233 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1786PDF: 776HTML: 2353 -
Clinical and laboratory features of Hemoglobin La Desirade variant in association with sickle cell and alpha thalassemia genes Clinical & laboratory features of Hb La Desirade trait and compound heterozygous for Hb La Desirade and HbS Hemoglobin.
1880PDF: 519HTML: 313 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2091PDF: 1641HTML: 806 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
883PDF: 138HTML: 222 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2823PDF: 869HTML: 15026Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 342 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1422PDF: 1002HTML: 445 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4488PDF: 1804HTML: 1124 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
894PDF: 500HTML: 1313 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
1055PDF: 793HTML: 129 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2678PDF: 848HTML: 5378 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1593PDF: 935HTML: 386 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1540HTML: 659PDF: 885 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8255PDF: 4459HTML: 7570 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1476PDF: 728HTML: 1188Untitled: 205Untitled: 169Untitled: 158Untitled: 171Untitled: 182 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3874PDF: 1652HTML: 866Figures . Eliassian: 257 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4064PDF: 1102HTML: 3901Untitled: 192Cneo. Fig.1: 129Untitled: 124Untitled: 149Untitled: 158 -
Mantle cell lymphoma relapsing at the lymphedematous arm.
1760PDF: 728HTML: 3829







